CLA supplementation was found to modulate inflammatory cytokines, maintain the mucosal barrier, and revert microbiota changes in the intestines of mice with Dextran sulfate sodium (DSS)-induced colitis (14). The gene discussed is SELPLG; the disease is colitis.